Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Total Debt (2016 - 2025)

Historic Total Debt for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to $45.1 billion.

  • Bristol Myers Squibb's Total Debt fell 914.02% to $45.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $45.1 billion, marking a year-over-year decrease of 914.02%. This contributed to the annual value of $45.1 billion for FY2025, which is 914.02% down from last year.
  • According to the latest figures from Q4 2025, Bristol Myers Squibb's Total Debt is $45.1 billion, which was down 914.02% from $49.0 billion recorded in Q3 2025.
  • Bristol Myers Squibb's 5-year Total Debt high stood at $55.7 billion for Q1 2024, and its period low was $37.6 billion during Q3 2023.
  • For the 5-year period, Bristol Myers Squibb's Total Debt averaged around $45.0 billion, with its median value being $45.0 billion (2022).
  • In the last 5 years, Bristol Myers Squibb's Total Debt plummeted by 1588.1% in 2023 and then skyrocketed by 4717.68% in 2024.
  • Over the past 5 years, Bristol Myers Squibb's Total Debt (Quarter) stood at $44.6 billion in 2021, then dropped by 11.75% to $39.3 billion in 2022, then increased by 1.15% to $39.8 billion in 2023, then rose by 24.83% to $49.6 billion in 2024, then fell by 9.14% to $45.1 billion in 2025.
  • Its last three reported values are $45.1 billion in Q4 2025, $49.0 billion for Q3 2025, and $49.2 billion during Q2 2025.